narciclasine has been researched along with Mouth Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MK; Chuang, YC; Ho, HY; Hsieh, MJ; Lin, CC; Lo, YS; Shieu, MK | 1 |
1 other study(ies) available for narciclasine and Mouth Neoplasms
| Article | Year |
|---|---|
Narciclasine suppresses oral cancer metastasis by modulating cathepsin B and extracellular signal-related kinase pathways.
Topics: Amaryllidaceae Alkaloids; Cathepsin B; Extracellular Signal-Regulated MAP Kinases; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases | 2023 |